Evidence map›Paper›PMID 33936838›Full record

ArticleJournal of analytical methods in chemistry2021

Identification of Metabolites of Aurantio-Obtusin in Rats Using Ultra-High-Performance Liquid Chromatography-Q-Exactive Orbitrap Mass Spectrometry with Parallel Reaction Monitoring.

Shi-Han Qin, Yuan Xu, Kai-Lin Li, Kai-Yan Gong, Jie Peng, Si-Lin Shi, Fang Yan, Wei Cai

Open access · goldAbstract read
In one paragraph

Article in Journal of analytical methods in chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Active Components ofAntioxidants (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Shi-Han QinSchool of Pharmacy, Weifang Medical University, Weifang 261000, China.ORCID https://orcid.org/0000-0002-7375-2735
Yuan XuDepartment of TCM Rheumatism, China-Japan Friendship Hospital, Beijing 100029, China.ORCID https://orcid.org/0000-0003-3189-4775
Kai-Lin LiSchool of Pharmaceutical Sciences, Hunan Province Key Laboratory of Antiboby-Based Drug and Intelligent Delivery System, Hunan University of Medicine, Huaihua 418000, China.ORCID https://orcid.org/0000-0003-1372-8140
Kai-Yan GongSchool of Pharmaceutical Sciences, Hunan Province Key Laboratory of Antiboby-Based Drug and Intelligent Delivery System, Hunan University of Medicine, Huaihua 418000, China.ORCID https://orcid.org/0000-0002-1601-8446
Jie PengSchool of Pharmaceutical Sciences, Hunan Province Key Laboratory of Antiboby-Based Drug and Intelligent Delivery System, Hunan University of Medicine, Huaihua 418000, China.ORCID https://orcid.org/0000-0003-4135-8028
Si-Lin ShiSchool of Pharmaceutical Sciences, Hunan Province Key Laboratory of Antiboby-Based Drug and Intelligent Delivery System, Hunan University of Medicine, Huaihua 418000, China.ORCID https://orcid.org/0000-0002-4740-9685
Fang YanSchool of Pharmacy, Weifang Medical University, Weifang 261000, China.ORCID https://orcid.org/0000-0003-4980-3800
Wei CaiSchool of Pharmaceutical Sciences, Hunan Province Key Laboratory of Antiboby-Based Drug and Intelligent Delivery System, Hunan University of Medicine, Huaihua 418000, China.ORCID https://orcid.org/0000-0002-8849-0280
Hunan University · CNWeifang Medical University · CNChina-Japan Friendship Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aurantio-obtusin (AO) is a major anthraquinone compound isolated from

Identifiers

PMID33936838
PMCPMC8062173
OpenAlexW3154077973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.